Quantbot Technologies’s Akebia Therapeutics AKBA Stock Holding History

Quantbot Technologies’s Portfolio AKBA Stock Details AKBA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$16.8K	Buy	+12,095	New	+$16.6K	﹤0.01%	1500
2024 Q4	–	Sell	-2,116	Closed	-$2.79K	–	1437
2024 Q3	$2.79K	Buy	+2,116	New	+$2.83K	﹤0.01%	1380
2020 Q4	–	Sell	-4,800	Closed	-$12K	–	1247
2020 Q3	$12K	Buy	4,800 +4,300	+860%	+$37.7K	﹤0.01%	1077
2020 Q2	$6K	Buy	+500	New	+$5.17K	﹤0.01%	981
2020 Q1	–	Sell	-4,300	Closed	-$27K	–	872
2019 Q4	$27K	Buy	+4,300	New	+$20.4K	﹤0.01%	1028
2015 Q4	–	Sell	-10,970	Closed	-$105K	–	1048
2015 Q3	$105K	Buy	+10,970	New	+$101K	0.02%	747

Other funds holding AKBA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Quantbot Technologies's AKBA Position: Q1 2026 in Review

Quantbot Technologies opened a new position in Akebia Therapeutics (AKBA) in Q1 2026: 12,095 shares worth $16.8K. The stake represents ﹤0.01% of the portfolio and ranks #1500 among its holdings. This is a return to the name: Quantbot Technologies previously reported a position in AKBA as recently as Q3 2024.

Quantbot Technologies first reported a position in AKBA in Q3 2015 and has held it in 6 quarters since. The position peaked at $105K in Q3 2015. 171 funds tracked by Wall St. Rank hold AKBA as of Q1 2026.

Quantbot Technologies held 12,095 shares of Akebia Therapeutics worth $16.8K as of Q1 2026.
Akebia Therapeutics was a new Quantbot Technologies position in Q1 2026.
Akebia Therapeutics made up ﹤0.01% of Quantbot Technologies's portfolio in Q1 2026, its #1500 holding.
Quantbot Technologies first reported a position in Akebia Therapeutics in Q3 2015 and has held it in 6 quarters since.
Quantbot Technologies's Akebia Therapeutics position peaked at $105K in Q3 2015.
171 funds tracked by Wall St. Rank held Akebia Therapeutics as of Q1 2026.

Based on Quantbot Technologies's 13F filing for Q1 2026, filed 13 May 2026.